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week 16 post the first Lupron treatment in the older monkeys
but no increase was observed in the younger monkeys. No
differences in serum CTxII due to OVX were noted in either group.
However in the younger monkeys, Lupron treatment resulted in
increases in COMP and CPII. COMP was significantly increased
compared to pre Lupron treatment two weeks after the first
Lupron injection and remained significantly elevated through
week 12. CPII in the younger monkeys did not increase until 12
weeks after the first Lupron injection. In the older monkeys, no
differences in COMP and CPII due to OVX were noted.
Conclusions: In summary, this data demonstrated that ani-
mal age affects cartilage biomarker levels. Secondly, medical
ovariectomy was able to cause increases in cartilage turnover
and the response varied depending upon the age of the ani-
mal. These data suggest some of these biomarkers could be
useful in monkeys to monitor the response to experimental OA
drugs.
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Purpose: Aurothiomalate is used in the treatment of arthri-
tis. Prostaglandin E2 (PGE2) production is increased in various
forms of arthritis. The key enzymes in inflammatory PGE2 syn-
thesis are inducible cyclooxygenase-2 (COX-2) and inducible
microsomal prostaglandin E synthase-1 (mPGES-1). Two other
forms of prostaglandin E synthase (PGES), microsomal PGES-2
(mPGES-2) and cytosolic PGES (cPGES) are ubiquitously ex-
pressed. In the present study, we investigated the effects of
aurothiomalate on interleukin-1β (IL-1β) -induced COX-2 and
PGES expression and subsequent PGE2 production in immortal-
ized murine H4 chondrocytes and in human osteoarthritic (OA)
cartilage.
Methods: Cartilage tissue was obtained from the leftover pieces
of total knee replacement surgery from patients with OA. PGE2
production was measured by RIA, protein expression was mea-
sured by Western blot and mRNA expression was measured by
quantitative PCR.
Results: Aurothiomalate inhibited IL-1β -induced PGE2 produc-
tion in chondrocytes and in human cartilage. Aurothiomalate
inhibited also COX-2 and mPGES-1 expression but did not have
an effect on mPGES-2 or cPGES. Aurothiomalate enhanced
COX-2 mRNA degradation in IL-1β -treated chondrocytes. This
mechanism may well explain the inhibitory effect of aurothioma-
late on COX-2 expression.
Conclusions: Aurothiomalate suppressed IL-1β -induced COX-
2 and mPGES-1 expression in chondrocytes and in human
OA cartilage. The results suggest a novel anti-inflammatory
mechanism for aurothiomalate.
P92 – Table 1. Serum levels (mean±SD) of C2C, Coll2-1 and Coll2-1NO2 biomarkers in wild-type (WT) and biglycan/fibromodulin double-deficient mice (DKO).
C2C (ng/ml) Coll2-1 (nM) Coll2-1NO2 (nM)
Age (days) WT DKO p WT DKO p WT DKO p
49 / / / 200±30 222±31 0.06 1.38±0.22 2.22±0.42 0.000
66 32±16 52±14 0.001 / / / / / /
81 / / / 245±40 281±61 0.06 1.90±0.38 1.63±0.32 0.053
95 / / / 305±32 362±60 0.005 1.81±0.54 2.89±0.67 0.000
141 30±16 50±26 0.03 264±24 303±35 0.008 2.37±0.24 2.04±0.41 0.027
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Purpose: Compared to wild-type mice (WT), biglycan/fibromod-
ulin double deficient mice (DKO) develop premature and severe
knee OA. In this study, we aimed at comparing 1) type II collagen
catabolism between the 2 genotypes and 2) the usefulness of
C2C, Coll2-1 and Coll2-1NO2 biomarkers to evaluate collagen
catabolism in an animal model of osteoarthritis.
Methods: Serum levels of the type II collagen biomarkers C2C,
Coll2-1 and Coll2-1NO2 were determined in 15 WT and 15 DKO
at the age of 66 and 141 days for C2C and at the age of 49, 81, 95
and 141 days for Coll2-1 and Coll2-1NO2. Mice were sacrificed
at day 141. C2C, Coll2-1 and Coll2-1NO2 immunohistochemistry
was performed on coronal histological sections of knee joints.
Results: The mean serum concentrations of Coll2-1 and C2C
were significantly higher in DKO than in WT at all time points
(see Table 1). The DKO/WT ratios for these 2 biomarkers re-
mained approximately constant with time and were ∼1.63 for
C2C and ∼1.15 for coll2.1. In contrast, Coll2-1NO2 displayed
cyclic variations with a DKO/WT ratio ∼1.60 at day 49 and 95 but
=0.86 at intermediate time points (day 81 and 141) (see Table).
In both genotypes, immunostainings with Coll2-1, Coll2-1NO2
and C2C labelled some fibroblasts in tendons and menisci as
well as the chondrocytes above the tidemark in articular cartilage
whereas chondrocytes in the growth plate remained unstained.
For the 3 biomarkers, extracellular stainings was limited to fi-
brocartilage areas in tendons and menisci from both genotypes
and to some of the focal lesions of the biglycan/fibromodulin
deficient cartilage. No extracellular staining was observed in WT
cartilage.
Conclusions: Our study demonstrates a higher type II collagen
catabolism in the biglycan/fibromodulin double-deficient mouse.
The different DKO/WT ratios observed with C2C, Coll2-1 and
Coll2-1NO2 suggest that these 3 serum biomarkers give com-
plementary rather than redundant information on type II collagen
catabolism. C2C and Coll2-1 are useful to directly monitor col-
lagen degradation in animal models of osteoarthritis whereas
Coll2-1NO2 is less suitable as it requires the additional presence
of oxidative stress.
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Purpose: Osteoarthritis is considered to have heterogeneous
metabolism, involving all joint tissues. However, it is not known
in whom the disease will progress. The latter is characterized
